Dishman Carbogen Amcis has informed that the meeting of the Board of Directors of the Company will be held on May 08, 2019, to consider, take on record and approve the Audited Financial Results of the Company for the quarter and year ended on March 31, 2019 and to consider and recommend Final Dividend on equity shares of the Company, if any. In view of the same and pursuant to the Code of Conduct to Regulate, Monitor and Report Trading by Designated Person(s) of the Company, the Trading Window for dealing in Securities by Designated Persons and their immediate relative(s) has been closed from April 03, 2019 to May 10, 2019. It is pertaining to note that the Company has made necessary disclosure regarding closure of Trading Window on April 03, 2019 to the Stock Exchanges.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: